EL
SRNE

EMFO LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

EMFO LLC’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-209,398
Closed -$186K – 324
2022
Q4 		$186K Sell
209,398
-21,319
-9% -$28.3K 0.19% 86
2022
Q3 		$362K Hold
230,717
– – 0.34% 63
2022
Q2 		$464K Hold
230,717
– – 0.47% 53
2022
Q1 		$538K Buy
230,717
+9,500
+4% +$29.6K 0.49% 49
2021
Q4 		$1.03M Sell
221,217
-11,791
-5% -$73.2K 0.91% 30
2021
Q3 		$1.78M Sell
233,008
-110,000
-32% -$933K 1.57% 23
2021
Q2 		$3.32M Buy
+343,008
New +$2.73M 2.91% 4

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

EMFO LLC's SRNE Position: Q1 2023 in Review

EMFO LLC sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 209,398 shares — an estimated $186K sold.

EMFO LLC first reported a position in SRNE in Q2 2021 and held it in 7 quarters. The position peaked at $3.32M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • EMFO LLC reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • EMFO LLC sold 209,398 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $186K.
  • EMFO LLC first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 7 quarters.
  • EMFO LLC's Sorrento Therapeutics, Inc. position peaked at $3.32M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on EMFO LLC's 13F filing for Q1 2023, filed 8 May 2023.